Cargando…
Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)
Recent randomized controlled multi-center trials JUPITER, CANTOS and COLCOT impressively demonstrated the effect of anti-inflammatory therapy on secondary prevention of cardiovascular events. These studies also rapidly re-vitalized the question of whether the C-reactive protein (CRP), the prototype...
Autores principales: | Zaczkiewicz, Myron, Kostenzer, Katharina, Graf, Matthias, Mayer, Benjamin, Zimmermann, Oliver, Torzewski, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999566/ https://www.ncbi.nlm.nih.gov/pubmed/35407370 http://dx.doi.org/10.3390/jcm11071762 |
Ejemplares similares
-
C-Reactive Protein in Human Atherogenesis: Facts and Fiction
por: Zimmermann, Oliver, et al.
Publicado: (2014) -
C-Reactive Protein and Arteriosclerosis
por: Torzewski, Jan, et al.
Publicado: (2014) -
Animal Models of C-Reactive Protein
por: Torzewski, Michael, et al.
Publicado: (2014) -
The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020) -
Therapeutic Lowering of C-Reactive Protein
por: Jimenez, Rachel V., et al.
Publicado: (2021)